Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00396591
What this trial is testing

AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant Ascites

Who this might be right for
Ovarian Neoplasms
Sanofi 16
Testing effectiveness (Phase 2)UnknownNCT00622726
What this trial is testing

Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
The University of Texas Health Science Center, Houston 150
Not applicableStudy completedNCT04378972
What this trial is testing

Anti-inflammatory Effect of Curcumin, Homotaurine, Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
University of Molise 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743632
What this trial is testing

Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC

Who this might be right for
Breast CancerTriple Negative Breast Cancer
University of Kansas Medical Center 110
Not applicableStudy completedNCT07689487
What this trial is testing

Effects of Cyclical Blood Flow Restriction Exercise on Muscle Hypertrophy and Capillaries in Older Adults

Who this might be right for
Sarcopenia in ElderlyMuscle AtrophyAging
Akdeniz University 31
Testing effectiveness (Phase 2)Study completedNCT00542048
What this trial is testing

A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases

Who this might be right for
Liver CancerNeoplasm Metastasis
MediGene 20
Testing effectiveness (Phase 2)UnknownNCT04156958
What this trial is testing

Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma

Who this might be right for
Biliary Tract Adenocarcinoma
Sichuan University 33
Post-approval studies (Phase 4)Study completedNCT00189592
What this trial is testing

Plantar Fasciosis Treatment Using Coblation

Who this might be right for
Plantar Fasciitis
ArthroCare Corporation 45
Very early researchStudy completedNCT00411333
What this trial is testing

Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
National Eye Institute (NEI) 100
Testing effectiveness (Phase 2)Study completedNCT00023725
What this trial is testing

Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)UnknownNCT03393689
What this trial is testing

RGD PET/MRI in Sporadic Vestibular Schwannoma

Who this might be right for
Acoustic Neuroma
Rigshospitalet, Denmark 40
Large-scale testing (Phase 3)Study completedNCT01223027
What this trial is testing

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Novartis Pharmaceuticals 564
Large-scale testing (Phase 3)UnknownNCT02396888
What this trial is testing

Effects of Local Insulin on Wound Angiogenesis

Who this might be right for
Angiogenesis
Hospital Central "Dr. Ignacio Morones Prieto" 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05210413
What this trial is testing

Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults

Who this might be right for
Refractory or Recurrent Solid Tumor
University Hospital, Bordeaux 80
Testing effectiveness (Phase 2)UnknownNCT02930954
What this trial is testing

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Caicun Zhou 180
Not applicableActive Not RecruitingNCT03185039
What this trial is testing

Predictive Impact of MMP2 and MMP9 Levels for Patients With Metastatic Kidney Cancer Treated With Anti-angiogenic Agents

Who this might be right for
Kidney Cancer
Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT02941419
What this trial is testing

Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis

Who this might be right for
Critical Limb Ischemia
University of Jordan 10
Testing effectiveness (Phase 2)Study completedNCT00083577
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 250
Large-scale testing (Phase 3)Study completedNCT02901236
What this trial is testing

Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma

Who this might be right for
Glaucoma
Athens Vision Eye Institute 40
Not applicableLooking for participantsNCT06549907
What this trial is testing

A Biomarker Exploratory Study of Dual Blockade of PD1/PDL1 and CTLA4 and Anti-angiogenic Therapy

Who this might be right for
MSS Metastatic Colorectal CancersMSI Solid Tumors Refractory to PD1/PDL1 Antibody Monotherapy
Peking University Cancer Hospital & Institute 50
Next Page